Renu Gupta - Concepedia

Author

Renu Gupta

Insmed (United States)

Also Known As

R Gupta, R. B. L. Gupta, R. Gupta, R.B.L. Gupta, Renu B. Gupta, Renu Gupta

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Insmed (United States)University of Toronto The University of Texas Health Science Center at Tyler Istituti di Ricovero e Cura a Carattere Scientifico Università Cattolica del Sacro Cuore

About

Renu Gupta is an author at Insmed (United States) specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	850
2	Health Sciences	3	3	214
3	Public Health	2	2	54
4	Allergy	1	1	98
5	Epidemiology	1	1	11

Renu Gupta

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial Christopher G. Wood, Pramod K. Srivastava, Ronald M. Bukowski, The Lancet UrologySurgical OncologyVersus ObservationGenitourinary CancerMedicine	2008	328
Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group Alessandro Testori, Jon Richards, Eric D. Whitman, Journal of Clinical Oncology	2008	252
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease Kenneth N. Olivier, David E. Griffith, Gina Eagle, American Journal of Respiratory and Critical Care Medicine	2016	242
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis Ganesh Raghu, Bernt van den Blink, Mark J. Hamblin, JAMA	2018	221
Phase II studies of nebulised Arikace in CF patients with<i>Pseudomonas aeruginosa</i>infection John P. Clancy, Lieven Dupont, Michael W. Konstan, Thorax	2013	218
Lack of Adherence to Evidence-based Treatment Guidelines for Nontuberculous Mycobacterial Lung Disease Jennifer Adjemian, D. Rebecca Prevots, Jack R. Gallagher, Annals of the American Thoracic Society	2014	149
Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection Ólanrewaju O. Okusanya, Sujata M. Bhavnani, Jeffrey Hammel, Antimicrobial Agents and Chemotherapy Antibiotic AdjuvantAntimicrobial ChemotherapyDrug ResistanceNovel Liposomal AmikacinRespiratory Infection	2009	101
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study Ganesh Raghu, Bernt van den Blink, Mark J. Hamblin, The Lancet Respiratory Medicine Translational MedicineFibrosisAntifibrotic TherapyOpen-label Extension StudyAdvanced Lung Disease	2019	99
Delivery of Aerosolized Liposomal Amikacin as a Novel Approach for the Treatment of Nontuberculous Mycobacteria in an Experimental Model of Pulmonary Infection Sasha J. Rose, Mary E. Neville, Renu Gupta, PLoS ONE Inflammatory Lung DiseaseLung InflammationKlebsiella PneumoniaeAerosolized Liposomal AmikacinAntimicrobial Chemotherapy	2014	98
Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung Alexander J. Chou, Renu Gupta, Moshe D. Bell, Pediatric Blood & Cancer	2012	65

Page 1